<DOC>
	<DOCNO>NCT01720537</DOCNO>
	<brief_summary>This study evaluate safety , tolerability immunogenicity single , ascend multiple fix subcutaneous intravenous administration PF 05335810 hypercholesterolemic subject add daily statin dose .</brief_summary>
	<brief_title>A Study To Assess The Safety Of PF-05335810 In Hypercholesterolemic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<criteria>On stable daily dos statin 45 day prior receive study treatment . Fasting LDL C equal great 80 mg/dL screen visit approximately 1 week prior randomization . History cardiovascular cerebrovascular event procedure within one year randomization . Poorly control type 1 type 2 diabetes mellitus ( define HbA1c &gt; 9 % ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>High Cholesterol</keyword>
	<keyword>Dyslipidemia</keyword>
</DOC>